Pricing Log in Create free account

Inotiv, Inc. (NOTVQ) vs XWELL, Inc. (XWEL)

Inotiv, Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $7.5M against $2.8M — 2.7× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −7.58%. Inotiv, Inc. has the higher net margin (−17.1% vs −117.8%) and the lower return on invested capital (−6.19% vs 0.00%). Across the 19 metrics below, Inotiv, Inc. leads on 10 and XWELL, Inc. on 9.

Valuation

Metric NOTVQ XWEL Diagnostics & Research median
P/E n/m n/m 35.56
P/S 0.00 0.22 4.37
P/B 0.00 0.75 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA 60.99 0.02 24.35
EV/Sales 1.57 (0.01) 5.51
Earnings yield (25,300.00%) (728.77%) (1.89%)
Free cash flow yield (2,858.05%) (217.51%) (0.15%)

Profitability

Metric NOTVQ XWEL Diagnostics & Research median
Gross margin 22.94% 34.34% 50.89%
Operating margin (9.48%) (61.31%) (8.57%)
Net margin (17.14%) (117.83%) (6.37%)
Free cash flow margin (1.95%) (47.65%) 0.00%
Return on equity (74.09%) (557.21%) (2.92%)
Return on assets (11.85%) (155.10%) (6.71%)
Return on invested capital (6.19%) 0.00% 0.00%

Growth

Metric NOTVQ XWEL Diagnostics & Research median
Revenue growth (TTM) 5.61% (7.58%) 7.69%
EPS growth (last fiscal year) 49.64% (38.80%) 25.92%
Revenue growth, 5-year CAGR 53.36% 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NOTVQ XWEL Diagnostics & Research median
Debt to equity 5.49 0.00 0.11
Current ratio 0.27 2.27 2.02
Net debt to EBITDA 12.68 (0.08) 0.70

Dividend

Metric NOTVQ XWEL Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric NOTVQ XWEL Diagnostics & Research median
Market cap 2.79m 7.45m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack